Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00793741 · ClinicalTrials.gov registry record
Measurement of Glucose Metabolism in Humans Using Magnetic Resonance at 4 Tesla. Substudy: Hypoglycemia Unawareness
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 19
- Enrollment target
NCT00793741 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 19 participants.
The verdict
NCT00793741 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether islet transplantation alters brain glucose concentrations in patients with type 1 diabetes, recurrent hypoglycemia, and hypoglycemia unawareness when compared to that measured prior to transplant in the same subjects.
Interventions
- DRUG somatostatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2007-12 |
| Est. Completion | 2017-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00793741
The ClinicalTrials.gov registry entry for NCT00793741 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which somatostatin is the first listed.
NCT00793741 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00793741 about?
NCT00793741 is a clinical study titled "Measurement of Glucose Metabolism in Humans Using Magnetic Resonance at 4 Tesla. Substudy: Hypoglycemia Unawareness". The purpose of this study is to determine whether islet transplantation alters brain glucose concentrations in patients with type 1 diabetes, recurrent hypoglycemia, and hypoglycemia unawareness when compared to that measured prior to transplant in the same subjects.
What is the current status of trial NCT00793741?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2007-12. Estimated completion is 2017-03.
What interventions are being tested in trial NCT00793741?
The interventions under investigation include: somatostatin (DRUG).
Who is sponsoring clinical trial NCT00793741?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.